Trends and correlation of antibiotic susceptibility and antibiotic consumption at a large teaching hospital in China (2007–2016): a surveillance study

References

• World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Switzerland, Geneva; 2014 Available from:  https://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed July 1, 2018.
   Google Scholar
• U.S. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States. United States; 2013 Available from: http://www.cdc.gov/drugresistance/threat-report-2013/index.html. Accessed July 1, 2018.
   Google Scholar
• World Health Organization. High levels of antibiotic resistance found worldwide, new data shows; 2018 Available from: http://www.who.int/news-room/detail/29-01-2018-high-levels-of-antibiotic-resistance-found-worldwide-new-data-shows. Accessed 71, 2018.
   Google Scholar
• Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect. 2016;22(Suppl 1):S9–S14. doi:10.1016/j.cmi.2016.01.00127000156
   PubMed Web of Science ®Google Scholar
• Xiao YH, Giske CG, Wei ZQ, Shen P, Heddini A, Li LJ. Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat. 2011;14(4–5):236–250. doi:10.1016/j.drup.2011.07.00121807550
   PubMed Web of Science ®Google Scholar
• U.S. Centers for Disease Control and Prevention. Antibiotic Use in the United States, 2017: Progress and Opportunities. United States, U.S.: Atlanta; 2017.
   Google Scholar
• Falagas ME, Michalopoulos A. Polymyxins: old antibiotics are back. Lancet. 2006;367(9511):633–634. doi:10.1016/S0140-6736(06)68241-X16503447
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5): e61–e111. doi:10.1093/cid/ciw504
   Web of Science ®Google Scholar
• Bao L, Peng R, Wang Y, et al. Significant reduction of antibiotic consumption and patients’ costs after an action plan in China, 2010-2014. PLoS One. 2015;10(3):e0118868. doi:10.1371/journal.pone.011886825767891
   PubMed Web of Science ®Google Scholar
• Sun J, Shen X, Li M, et al. Changes in patterns of antibiotic use in Chinese public hospitals (2005-2012) and a benchmark comparison with Sweden in 2012. J Glob Antimicrob Resist. 2015;3(2):95–102. doi:10.1016/j.jgar.2015.03.00127873677
   PubMed Web of Science ®Google Scholar
• Hu F, Chen S, Xu X, et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. J Med Microbiol. 2012;61(Pt 1):132–136. doi:10.1099/jmm.0.036483-021903823
   PubMed Web of Science ®Google Scholar
• Xu J, Duan X, Wu H, Zhou Q. Surveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based study. PLoS One. 2013;8(11):e78604. doi:10.1371/journal.pone.007860424250801
   PubMed Web of Science ®Google Scholar
• Zhou T, Zhang X, Guo M, et al. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China. Jpn J Infect Dis. 2013;66(2):96–102.23514904
   PubMed Web of Science ®Google Scholar
• Zou YM, Ma Y, Liu JH, et al. Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013). Eur J Clin Microbiol Infect Dis. 2015;34(4):795–803. doi:10.1007/s10096-014-2293-625487131
   PubMed Web of Science ®Google Scholar
• Chen S, Hu F, Liu Y, Zhu D, Wang H, Zhang Y. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China. Am J Infect Control. 2011;39(9):e55–e60. doi:10.1016/j.ajic.2011.02.00921705111
   PubMed Web of Science ®Google Scholar
• Tan CK, Tang HJ, Lai CC, Chen YY, Chang PC, Liu WL. Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010. J Microbiol Immunol Infect. 2015;48(5):540–544. doi:10.1016/j.jmii.2014.02.00424685280
   PubMedGoogle Scholar
• Yang P, Jiang SP, Lu XY. Effectiveness of continuous improvement by a clinical pharmacist-led guidance team on the prophylactic antibiotics usage rationality in intervention procedure at a Chinese tertiary teaching hospital. Ther Clin Risk Manag. 2017;13:469–476. doi:10.2147/TCRM.S13193728442914
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 27th CLSI supplement M100 United States, U.S.: Wayne; 2017
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2018. Norway: Oslo; 2017.
   Google Scholar
• Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6):e619–e629. doi:10.1016/S2214-109X(18)30186-429681513
   PubMed Web of Science ®Google Scholar
• Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RA. Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy? Expert Opin Pharmacother. 2016;17(6):761–781. doi:10.1517/14656566.2016.114565826799840
   PubMed Web of Science ®Google Scholar
• Rafailidis PI, Falagas ME. Options for treating carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2014;27(6):479–483. doi:10.1097/QCO.000000000000010925259809
   PubMed Web of Science ®Google Scholar
• Melnyk AH, Wong A, Kassen R. The fitness costs of antibiotic resistance mutations. Evol Appl. 2015;8(3):273–283. doi:10.1111/eva.1219625861385
   PubMed Web of Science ®Google Scholar
• Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 2010;8(4):260–271. doi:10.1038/nrmicro231920208551
   PubMed Web of Science ®Google Scholar
• Epstein L, Mu Y, Belflower R, et al. Risk factors for invasive methicillin-resistant staphylococcus aureus infection after recent discharge from an acute-care hospitalization, 2011-2013. Clin Infect Dis. 2016;62(1):45–52. doi:10.1093/cid/civ77726338787
   PubMed Web of Science ®Google Scholar
• Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033. doi:10.1038/nrdp.2018.3329849094
   PubMed Web of Science ®Google Scholar
• Bassetti M, Peghin M, Pecori D. The management of multidrug-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2016;29(6):583–594. doi:10.1097/QCO.000000000000031427584587
   PubMed Web of Science ®Google Scholar
• Ye ZK, Chen YL, Chen K, et al. Therapeutic drug monitoring of vancomycin: a guideline of the division of therapeutic drug monitoring, Chinese pharmacological society. J Antimicrob Chemother. 2016;71(11):3020–3025. doi:10.1093/jac/dkw25427494905
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Takesue Y, Ohmagari N, et al. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese society of chemotherapy and the Japanese society of therapeutic drug monitoring. J Infect Chemother. 2013;19(3):365–380. doi:10.1007/s10156-013-0599-423673472
   PubMed Web of Science ®Google Scholar
• Zhu YL, Hu LF, Mei Q, et al. Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin. J Antimicrob Chemother. 2012;67(11):2700–2706. doi:10.1093/jac/dks28022809703
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2016. Accessed 71, 2018.
   Google Scholar
• Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–187. doi:10.1016/S0140-6736(15)00473-026603922
   PubMed Web of Science ®Google Scholar
• Yang P, Chen Y, Jiang S, Shen P, Lu X, Xiao Y. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrob Resist Infect Control. 2018;7:137. doi:10.1186/s13756-018-0430-130479750
   PubMed Web of Science ®Google Scholar
• Li Y, Shen H, Zhu C, Yu Y. Carbapenem-resistant klebsiella pneumoniae infections among ICU admission patients in Central China: prevalence and prediction model. Biomed Res Int. 2019;2019:9767313.31032370
   PubMed Web of Science ®Google Scholar
• Liu P, Li X, Luo M, et al. Risk factors for carbapenem-resistant klebsiella pneumoniae infection: a meta-analysis. Microb Drug Resist. 2018;24(2):190–198. doi:10.1089/mdr.2017.006128749714
   PubMed Web of Science ®Google Scholar
• Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2:Cd003543.28178770
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Annual Epidemiological Report. Antimicrobial Resistance and Healthcare-associated Infections. Stockholm: ECDC; 2015.
   Google Scholar